The next 10 years in personalized medicine in cardiology

Affiliations

Editorial

Udaya S Tantry et al. Expert Rev Cardiovasc Ther. 2013 Aug.

. 2013 Aug;11(8):933-5.

doi: 10.1586/14779072.2013.814823.

No abstract available

Similar articles

Best medical intervention for arterial disease or wishful thinking.
Abbott A. Abbott A. Eur J Vasc Endovasc Surg. 2011 Apr;41(4):509-10. doi: 10.1016/j.ejvs.2011.01.008. Epub 2011 Feb 1. Eur J Vasc Endovasc Surg. 2011. PMID: 21285001 No abstract available.
Comments regarding 'Best medical therapy or wishful thinking in carotid disease? a single centre audit in Germany'.
Milner R. Milner R. Eur J Vasc Endovasc Surg. 2011 Apr;41(4):507-8. doi: 10.1016/j.ejvs.2010.12.019. Epub 2011 Jan 21. Eur J Vasc Endovasc Surg. 2011. PMID: 21256775 No abstract available.
[Pharmacological prevention of cardiovascular diseases].
Okovityĭ SV, Kulikov AN, Shulenin KS. Okovityĭ SV, et al. Eksp Klin Farmakol. 2011;74(11):43-7. Eksp Klin Farmakol. 2011. PMID: 22288160 Russian.
Personalized vascular medicine: individualizing drug therapy.
Degoma EM, Rivera G, Lilly SM, Usman MH, Mohler ER 3rd. Degoma EM, et al. Vasc Med. 2011 Oct;16(5):391-404. doi: 10.1177/1358863X11422251. Vasc Med. 2011. PMID: 22003003 Free PMC article. Review.
Cardiovascular pharmacogenetics of antihypertensive and lipid- lowering therapies.
Vanichakarn P, Hwa J, Stitham J. Vanichakarn P, et al. Curr Mol Med. 2014;14(7):849-79. doi: 10.2174/1566524014666140811115517. Curr Mol Med. 2014. PMID: 25109793 Review.

Words matter: distinguishing "personalized medicine" and "biologically personalized therapeutics".
Cherny NI, de Vries EG, Emanuel L, Fallowfield L, Francis PA, Gabizon A, Piccart MJ, Sidransky D, Soussan-Gutman L, Tziraki C. Cherny NI, et al. J Natl Cancer Inst. 2014 Oct 7;106(12):dju321. doi: 10.1093/jnci/dju321. Print 2014 Dec. J Natl Cancer Inst. 2014. PMID: 25293984 Free PMC article.